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Abstract. PC 10 is a monoclonal antibody against proliferating cell nuclear antigen 
(PCNA). The staining pattern in immunochemistry depends on fixation and detergent 
extraction treatment. The aim of this study was to validate the flow cytometric PCNA 
assay against Bromodeoxyuridine-labelling index (BrdUrd-LI) under different 
proliferative conditions in vitro. Expression of PCNA in methanol fixed cells with, and 
without, prior detergent extraction with EDTA/Triton was compared to BrdUrd- 
labelling index in NIH-3T3 fibroblasts and human Caski tumour cells in exponential 
phase and under confluent conditions. Serum stimulation and serum starvation 
conditions were studied. The results for BrdUrd-LI and PCNA-index after extraction 
showed good correlation for 3T3 fibroblasts and for Caski cells, with some differences 
for serum withdrawn Caski cells. There was no correlation between the number of cells 
that were positive for PCNA without extraction and BrdUrd-LI. Spheroid cells with 
G, -DNA-content showed an almost synchronous recruitment and progression through 
the cell cycle after trypsination and replating. Tightly bound PCNA paralleled this 
synchronicity whereas total PCNA did not change significantly. The results demonstrate 
that immunochemical detection of non-extractable PCNA-index gives similar results as 
compared with BrdUrd-labelling index under different proliferative conditions in v i m  
for different monolayer cell lines, whereas without extraction PCNA does not correlate 
with BrdUrd-LI in these fast growing cell lines due to its long half-life. PCNA expression 
parallels the progression through the cell cycle in V79 spheroids, a primitive model of 
tumour growth. 
Several markers (S phase fraction, Ki-67, different proto-oncogenes) are presently being 
evaluated as tools for determining the proliferative capacity of tumours (Yu, Woods & Levison 
1992). 
S phase fraction can be assessed by ['HI-thymidine labelling or by DNA flow cytometry. 
However, DNA histograms are difficult to evaluate for tumours with cell populations of different 
ploidy. Dolbeare et a/. (1983) published a non-radioactive method to determine S phase fraction 
using Bromodeoxyuridine (BrdUrd). Begg et al. (1985) described a method for calculation of 
Correspondence: Dr F. Lohr, Department of Oncological Diagnostics and Therapy, German Cancer 
93 
Research Center, Im Neuenheimer Feld 280,691 20 Heidelberg, Germany. 
94 F. Lohret al. 
potential doubling time (T,,,,,) from a single sample. In an ongoing phase I l l  study, Begg et a/. 
( 1992) showed that the BrdUrd-assay might help to choose between conventional or accelerated 
hyperfractionated radiotherapy in head and neck tumours. Potential doubling time and S phase 
labelling index (LI) provide strongly related information in this study. Though the BrdUrd-LI 
currently is the gold-standard for S phase detection, a cell inherent S phase marker would be 
desirable. 
Ki-67 is a monoclonal antibody that apparently determines growth fraction and is of good 
prognostic value in lymphoma and leukaemia. Its value in solid tumours has not finally been 
determined (Brown & Gatter 1990). The cDNA-sequence of the gene that codes for the Ki-67 
antigen has been completely sequenced and the definition of the antigen in molecular terms has 
recently been reviewed (Schliiter et ul. 1993, Duchrow, Gerdes & Schliiter 1994). 
PCNA was initially described as a corresponding antigen to an autoantibody in sera of 
patients with Lupus Erythematosus (Miyachi, Fritzler & Tan 1978) and is identical with the 
nuclear protein ‘Cyclin’ (Mathews et al. 1984). It is a non-histone protein with a molecular weight 
of 36 kD which functions as an auxiliary protein of DNA-polymerase delta (Prelich et ul. 1987). 
PCNA is expressed beginning in late G , ,  with a two to three-fold increase in S and a decrease at 
the S/G2 transition and during G? + M. Two intranuclear populations exist (Bravo & McDonald- 
Bravo 1984, Galand & Degraef 1989, Humbert et al. 1992). A tightly bound nucleolar form is 
only detectable from late G ,  to G z + M .  A second diffuse nucleoplasmic form, which can be 
extracted by an EDTA/Triton-containing lysing buffer prior to fixation with methanol (Landberg 
& Roos 1991). is detectable during the whole cell cycle and is probably PCNA that has left the 
replisomes, and is acting as a reserve pool. It is degraded with a half-life of 20 h (Bravo & 
McDonald-Bravo 1 9 87). 
PCNA is involved in DNA-repair and behaves like synthesis-associated PCNA in methanol 
or paraformaldehyde-Triton treatment (Shivji, Kenny & Wood 1992, Stivala et al. 1993, Toschi & 
Bravo 1988, Vriz et a/. 1992). After serum stimulation of quiescent cells, PCNA gene expression 
was detected by Northern blotting after 10 h, with a maximum after 16-18 h (Bravo & 
McDonald-Bravo 1984). PCNA is expressed after c-myc and c-fos following serum stimulation 
(Vriz et ( I / .  1992) and is necessary for the G, /S  transition that can be inhibited by antisense 
nucleotides (Jakulski et al. 1988). It seems to be one of the final events that lead to DNA 
replication (Bravo & McDonald-Bravo 1984). 
Results of immunohistochemical studies using PCNA on normal and tumour tissue have been 
conflicting. Depending on the method of fixation and the antibody that was applied, either the 
S phase fraction or the proliferation fraction were detected (Sasaki, Kurose & Ishida 1993). Thus, 
studying PCNA in vi/ro under different proliferative conditions may help to interpret in vivo data. 
For exponentially growing cell lines in vitro, a good correlation between BrdUrd-L1 and the 
tightly bound PCNA-index was shown (Landberg & Roos 199 1, Sasaki e ta / .  1993). 
We report on flow-cytometric detection of proliferating cell nuclear antigen (PCNA) in 
comparison with BrdUrd as an S phase marker using different rodent and human monolayer cell 
lines under different proliferative conditions in vitro, with and without detergent extraction prior 
to methanol fixation. Additionally, expression of PCNA in partially synchronized V79 spheroids 
was studied. 
MATERIALS A N D  M E T H O D S  
Cell lines and endpoints 
Caski human cervix carcinoma cells and NlH-3T3 mouse fibroblasts were grown as monolayer 
cultures in 20 ml culture flasks with RPMI 1640 medium, supplemented with 1% 1.-glutamine and 
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10% fetal calf serum (FCS) at 37°C in an atmosphere of 5% CO,. For serum starvation and 
stimulation experiments medium was first changed to RPMl 1640 containing 1'56 L-glutamin and a 
residual concentration of 1 Yo FCS to prevent cell-detaching for both exponentially growing cells 
and cells that were confluent for 6 days. Cells were then trypsinized (EDTA 0.2%; 2 X 3 rnin at 
37"C, Trypsin 0.2%; 5 min at 37"C, followed by blocking with 10% FCS-containing medium) and 
replated using medium supplemented with 10% FCS. Cells were trypsinized and harvested as 
described above, 24 h after serum withdrawal as well as 0, 4, 6, 11, 15 and 19 h after serum 
induction (exponentially growing 3T3 cells were more closely monitored after serum withdrawal 
(e.g. see Figure 4a)). They were then fixed, stained and analyzed as described below. V70 cells 
were grown as spheroids in spinner bottles with DMEM (1% L-glutamin, 10% FCS). After 
reaching a median diameter of approximately 300 pm, spheroids were disaggregated (Trypsin 
0.2"/0, 1 ml; EDTA 0.2%, 1 ml, 10 min at 37°C) and replated as single cells. Aliquots of these cells 
were harvested 0 , 2  (not shown), 4 ,5 ,6 ,8 ,  10, 12, 14 and 24 h after plating. 
BrdUrd-labelling 
Cells ( 5  x 1 0 h )  were incubated with BrdUrd ( I  5 pmol/l) for 45 min. Immediately afterwards they 
were trypsinized. No BrdUrd labelling was performed on V79 spheroids. 
Fixation and extraction 
After trypsination cells were resuspended in 600 pl PBS and the suspension was then divided into 
three equal portions. For BrdUrd-detection, cells were fixed in 3 m l  70"h ethanol at 4°C for 
30 min. For detection of total PCNA cells were fixed in 3 ml of absolute methanol at - 20°C for 
10 rnin, then kept at 4°C for 30 min. For detection of DNA-bound PCNA, soluble PCNA was 
extracted by incubating the cells in 500p1 EDTA 0.2% containing Triton X-100 (2.5 pl/ml) and 
BSA (5 pl/ml) for 15 min on ice, according to a protocol published by Landberg & Roos ( 199 1 ). 
Then the samples were fixed with methanol as described above. 
Immunochemical staining 
RrdUrd 
For BrdUrd detection a modification of the method originally described by Dolbeare et al. ( 1983) 
was used. DNA denaturation was performed with 2~ HCI in a waterbath at 37°C for 30min. 
Between all following steps cells were washed in 3 ml PBS and taken up in a 24 G syringe several 
times. 
The staining protocol is a standard two-step procedure. One millilitre of PBS containing BSA 
( 10 pl/ml) and Triton X- 100 (50 pl/ml) was used for further permeabilization and non-specific 
blocking for 15min at room temperature. The primary antibody (anti BrdUrd, B44, Becton 
Dickinson, San Jose, CA, USA) and, after washing, the FITC conjugated goat-anti-mouse IgG 
(Becton Dickinson) as a secondary antibody wcre used, each at a dilution of 1 : 10 in 100 pl PBS 
containing BSA (2 pl/ml) for 30 min at room temperature. DNA-staining was achieved with 
1.4 ml propidium iodide (20 pg/ml) together with RNAase (30 pg/ml) to remove double-strand 
RNA ( 15 min in the dark, room temperature). Samples were then stored at 4°C until analysis. For 
negative controls an irrelevant isotypic antibody was used as the primary antibody, or no primary 
antibody at all was used, for both extracted and methanol fixed nuclei. 
I'CNA 
No DNA denaturation was performed after fixation. Monoclonal anti-PCNA (PCl0, Dianova, 
Hamburg, Germany) was used as primary antibody at a dilution of 1 : 10. Otherwise, processing 
was performed as described above. 
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Figure 2. DNAjanti-BrdUrd plot5 with set gates for  exponentially growing 3T3 fibroblasts: a negative controls 
( irrelevant primary antibody). h ethanol fixation. 
Flow cytometry 
Analysis was performed with a FACScan flow cytometer (Becton Dickinson). Amplification had 
to be set differently for BrdUrd and PCNA-detection because of the influence of DNA 
denaturation but was identical for the detection of total and tightly bound PCNA. Negative 
controls for both extracted and non-extracted cells were used to determine instrument settings for 
comparable measurements. At least 10000 events were acquired for each data point. No live 
gating was performed since few doublets were measured. Remaining doublets were excluded by 
individual window settings for each measurement. Lower window levels for positive cells were set 
as shown in Figure 1 so that a maximum of 2% false positive cells were accepted for negative 
controls. Experiments were repeated. The results are plotted as the mean of at least two 
experiments. The difference between actual values and the mean was always less than 15%. 
R E  S U LTS 
Fixation and extraction 
Figure 1 shows biparametric plots of DNA content v. anti-PCNA-FITC fluorescence in negative 
controls (non-extracted, methanol fixed), detergent extracted and non-extracted cxponentially 
growing 3T3 cells after fixation with methanol. Staining after extraction gave good S phase 
specificity and the cut-off between positive and negative cells could be easily placed. Figure 2 
shows negative controls and anti-BrdUrd-staining for the same cells after ethanol fixation, which 
was superior to methanol fixation in this respect (not shown). 
3T3 fibroblasts 
The index for tightly bound PCNA after detergent extraction showed excellent correlation with 
BrdUrd-LI under all conditions examined for 3T3 mouse fibroblasts. After serum induction, 
tightly bound PCNA and BrdUrd-LI increased at the same time and this was paralleled by an 
increase of cells with an S phase DNA-content in the DNA profile (Figure 3) .  For both 
exponential and plateau-phase the number of cells expressing tightly bound PCNA paralleled the 
fraction of BrdUrd-positive cells after serum withdrawal and after serum induction within less 
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Figure 4. a BrdUrd-LI, total PCNA-index and tightly bound PCNA-index (all as "/.) after serum withdrawal 
(-24 h )  and serum induction (0 h)  for exponentially growing 3T3 fibroblasts. b BrdUrd-LI, total PCNA- 
index and tightly bound PCNA-index after serum withdrawal (-24 h )  and serum induction (0 h )  for 31'3 
fihrohlasts in plateau-phase (6 days of confluency). A, tightly hound PCNA index; 0 ,  BrdUrd-LI; 0.  tot i i l  
PCNA index. 
a b 
100 r ,*"..... .... *.-... 
0 .._._ . .............................. ...'- c 2 80 
-20 -15 -10 -5 0 5 10 15 20 
Time after serum-induct ion (h )  Time after serum-induct ion ( h )  
Figure 5 .  a BrdUrd-LI, total PCNA-index and tightly hound PCNA-index after serum withdrawal (-24 h) 
and serum induction (0  h )  for exponentially growing human Caski cells. b BrdUrd-LI, total PCNA-index and 
tightly hound PCNA-index after serum withdrawal (-24 h) and serum induction (0  h )  for human Cnski cells 
in plateau-phase (6  days of confluency). A ,  tightly bound PCNA index; 0 ,  BrdUrd-LI; 0 ,  total t'CNA indcx. 
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Figure 6. a PCNA-index at different times after disaggregation of V7Y spheroids and replating as monolayers. 
A ,  tightly bound PCNA index; * total PCNA index. b DNA profiles at different times after disaggregation of 
V79-spheroids and replating as monolayers. 
than 3% variation, except for the data at 10 h (Figure 4b), 15 and 19 h (Figure 4a) where a 
variation of 8 to 23% was seen (Figure 4a,b). Total PCNA was close to 100%, positive cells in all 
experiments (Figure 4a, b). 
Caski cells 
For Caski cells there was also a correlation between BrdUrd-LI and tightly bound PCNA index. 
While, however, after serum induction the fractions of positive cells were similar (Figure Sa,b), 
after serum withdrawal of exponentially growing cells up to 20% BrdUrd-positive cells could be 
detected while almost no cells were positive for tightly bound PCNA (Figure Sa). Similarly, almost 
30% BrdUrd-positive cells were observed with only 10% positivity for tightly bound PCNA for 
confluent cells prior to serum withdrawal. Yet, mean anti-BrdUrd fluorescence decreased parallel 
to the decrease in tightly bound PCNA (not shown). 
V79 spheroids 
The appearance of total PCNA and tightly bound PCNA paralleled the appearance of S phase 
cells in the DNA histogram after 4-6 h (Figure 6). Tightly bound PCNA declined as the S phase 
fraction declined when the partially synchronized cells progressed through the cell cycle. This was 
confirmed by determination of the maximum mitotic index (not shown). Total PCNA remained 
elevated. 
DISCUSSION 
In immunohistochemistry, using different anti-PCNA antibodies and different fixation protocols, 
either granular or diffuse nuclear staining was reported, resembling either the S phase fraction or 
values similar to the Ki-67-index (Bravo & McDonald-Bravo 1984, Bravo & McDonald-Bravo 
1987, Landberg & Roos 1991, Shrestha el a/. 1992, Sasaki et al. 1993). Its prognostic value has 
been discussed with some controversy (Sullivan & Mortimer 1993). Among others, one reason 
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may be that the above mentioned antibodies detect different epitopes which differ in stability to 
fixation (Roos et al. 1993). Studying PCNA in vitro under different proliferative conditions may 
help to interpret this in vivo data. 
Using flow cytometry instead of immunohistochemistry has the advantage of overcoming 
topical heterogeneity of PCNA-expression in biopsies. However, this may also be a disadvantage 
since information about the spatial distribution of proliferation is lost. Moreover, identification 
of PCNA-positive v. negative cells is more reliable with flow cytometry than with 
immunohistochemistry, since placement of the cut-off between negative and positive cells is easier 
than in histochemistry because antibody dilution influences the intensity of PCNA staining 
(McCormick eta/. 1993). 
Since the BrdUrd assay is currently the standard method for detection of S phase cells in cell 
cultures or tumours, any possible alternative method has to be compared to this standard. The 
resulting good S phase specificity and DNA profiles in our study with the antibody o f  the clonc 
PC 1 0  confirm the results of Landberg and Wilson (Landberg & Roos 199 1, Wilson et ul. 1992). 
As the functional association of PCNA with DNA-replication suggests, in our studies the 
tightly bound PCNA-index showed excellent correlation with BrdUrd-L1 for 3T3 mouse 
fibroblasts, except for the data points late after serum induction. However, these data points are in 
the steep parts of the curves and, thus, little variation in timing between induction and 
measurement may cause large variations in PCNA-expression. 
For human Caski cells there was also good correlation, although the results were not identical, 
since after serum starvation in exponentially growing cells up to 20% BrdUrd-positive cells could 
be detected, while almost no cells were positive for tightly-bound PCNA. For confluent cells prior 
to serum withdrawal there was also up to 25%) BrdUrd-positive cells with only 10% positive cells 
for tightly bound PCNA. However, mean anti-BrdUrd-fluorescence decreased, indicating a 
reduced rate of DNA-synthesis. 
The observed phenomenon suggests some remaining DNA-synthesis that is either 
independent of PCNA-expression under in vitro conditions of restrained growth (serum 
starvation and confluency) or which only requires small levels of PCNA whose fluorescence level 
is below our detection threshold (cut-off). This discrepancy is somewhat contradictory to the 
theory that malignant and benign cells that are adjacent to tumours show enhanced PCNA protein 
expression even when not cycling because of paracrine deregulation of protein transcription (Hall 
et a/. 1990). Howcver, studies which have suggested this mechanism have lacked a marker such as 
BrdUrd as a standard. Other authors did not find such a phenomenon (Bleiberg, Morret & 
Galand 1993). More recently, true growth stimulation (possibly paracrine) of cells was considered 
more likely (Scott el al. 1991). Yet, the possibility of deregulation should not totally be dismissed 
since there is evidence (Ottavio et al. 1990) of increased PCNA-expression at the mRNA-level in 
fully quiescent cells after destruction of intron 4 in the PCNA-gene. Another possible, but unlikely 
explanation, is that tightly bound PCNA might be more easily extractable in serum depleted Caski 
cells than in 3T3-cells. Increased PCNA protein expression without DNA-synthesis, on the other 
hand, was also observed (Sasaki et al. 1993) in vifro, indicating that there is not always an exact 
coordination between cell proliferation and PCNA-expression. 
The results with spheroids as a model for a 3-D-cell system with oxygen, proliferation and 
nutrient-gradients with most cells supposed to be in the G,, phase are in agreement with the results 
obtained from monolayer cells. The increase and decrease of tightly bound PCNA paralleled the 
appearance and disappearance of cells with S phase DNA-content after disaggregation. 
The results of our flow cytometric studies in all three cell lines confirm previous data obtained 
by immunoblotting techniques concerning the expression of PCNA after serum induction (Bravo 
& McDonald-Bravo 1987). Being close to 100% for all the performed experiments, even after 
PCNA v. BrdUrd in vitro 103 
24 h serum withdrawal, the total PCNA index does not reflect changes in proliferative status in 
these rapidly cycling cells, mainly due to the long half life of PCNA. However, the proliferative 
status of more slowly proliferating human tumours does not change as quickly as in cultured cells. 
Thus, the total PCNA content in human tumours might be correlated to tightly bound PCNA. 
The feasability of flow cytometric PCNA detection in human tumours has been reported (Danova 
et al. 1988, Teague & El-Naggar 1994, Inada et al. 1993). Correlation of total PCNA-content to 
tightly bound PCNA is suggested by the good rank correlation between the PCNA-index without 
extraction and the BrdUrd-LI in three rat tumour sublines and the variations in non-extracted 
PCNA-index between 5 and 70% in human head and neck tumours (Lohr et al. 1993, Wenz et ul. 
1994). However, a reason for this might be that, after disaggregation, some soluble PCNA is 
extracted and, even without detergent lysis, preferably tightly bound PCNA is measured in solid 
tumours. However, both theories provide a rationale for using PCNA as an operational marker of 
proliferation in human tumours. 
A C K N O W L E D G E M E N T S  
‘The authors thank Mrs Trinh and Mrs Haner for their expert maintenance of cell cultures and 
spheroids. 
R E F E R E N C E S  
HEGG, AC, HOFLAND I, VAN GLABEKKE M. BARTELINK H, HORIOT JC. (1992) Predictive value of potential 
doubling time for radiotherapy of head and neck tumor patients: Results from the EORTC cooperative 
trial 2285 I .  Sernin. Rudiut. Oncol. 2, 22. 
HEGG AC, MCNALLY NJ, SHRIEVE DC, KARCHER H. ( I  985) A method to measure the duration of  DNA- 
synthesis and the potential doubling time from a single sample. Cytornetty 6,620. 
HLEIBERG H, MORRET M, GALAND P. (1993) Correlation between jH-Thymidine and Proliferating Cell 
Nuclear Antigen (PCNA)/Cyclin indices in archival, formaldehyde-fixed human colorectal tissues. 
Eur. J.  Cuncer, 29A, 400. 
BRAVO R, MACDONALD-BRAVO H. (1984) Induction of the nuclear protein “cyclin” in quiescent mouse 3T3  
cells stimulated by serum and growth factors. Correlation with DNA-synthesis. EMHO Journd 3 . 3  177. 
BRAVO R, MACDONALD-BRAVO H. ( 1987) Existence of two populations of cyclin/proliferating cell nuclear 
antigen during the cell cycle: Association with DNA-replication sites. J .  Cell. Biol. 105, 1549. 
BROWN DC, CATER KC. ( 1990) Monoclonal antibody Ki-67: its use in histopathology. /~listopulhotogy 17, 
489. 
DANOVA M, RICCARDI A, GIORDANO M er at. ( 1  988) Cell cycle-related proteins: a flow cytotliiorometric study 
in human tumors. Biol. Cell. 64,23. 
DOLBEARE F, GRATZNER H, PALLAviciNi MG, GRAY JW. (I 983) Flow cytometric measurement of total DNA 
content and incorporated bromodeoxyuridine. l’roc. Natl. Acud. Sci. USA 80, 5573. 
DUCHROW M, GERDES J, S C H L ~ E R  C. ( 1994) The proliferation-associated Ki-67 protein: definition in 
molecular terms. Ce// Pro/$ 27,235. 
GALAND P, DEGRAEF C. (1 989) Cyclin/PCNA immunostaining as an alternative to tritiated thymidine pulse 
labelling for marking S phase cells in paraffin sections from animal and human tissues. Cell 7issur Kinet. 
22,383. 
HALL PA, LEVISON DA, WOODS A L  el a/. (1990) Proliferating cell nuclear antigen (PCNA) immuno- 
localization in paraffin sections: An index of cell proliferation with evidence of deregulated expression 
in some neoplasms. J .  Puthol. 162,285. 
HUMBERT C, SANTISTEBAN MS, USSON Y, ROBERT-NicoUD M. ( 1  992) Intranuclear co-location of newly 
replicated DNA and PCNA by simultaneous immunofluorescent labelling and confocal microscopy in 
MCF-7 cells. J .  Cell. Sci. 103,97. 
INADA T, IMURA J, ICHIKAWA A, OGATA Y, SHIMAMURA K. (1993) Proliferative activity of  gastric cancer 
assessed by immunostaining for proliferating cell nuclear antigen. J .  Surg. Oncol. 54, 146. 
104 F. Lohr et al. 
JAKULSKI D, DERIEL JK, MERCER WE, CALABREITA B, BASERCA R. ( I  988) Inhibition of cellular proliferation 
by antisense oligodeoxynucleotides to PCNA/Cyclin. Science 10, 1544. 
LANDRERG G, Roos G. ( 199 I ) Antibodies to proliferating cell nuclear antigen as S-phase probes in tlow 
cytometric cell cycle analysis. Cancer Hes. 51,4570. 
LotiR F, WENZ F, FLENTJE M, PESCHKE P, HAHN EW. (1993) Measurement of the proliferative activity o f  thrcc 
different sublines of the Dunning rat prostate tumor R3327. Struhlenther. Onkol. 7,438.  
MCCORMICK D, Yu C, HORBS C, HALL PA. (1993) The relevance of antibody concentration t o  the 
immunohistological quantification of cell proliferation-associated antigens. Histopurlinlogy 22, 543. 
MATHEWS MB, BERNSTEIN RM, FRANZA BR, CARRELS JI.  (1984) Identity of the proliferating cell nuclear 
antigen and cyclin. Nuture 309,374. 
MIYACHI K, FRITZLER MJ, TAN EM. (1978) Autoantibody to a nuclear antigen in proliferating cells. J. 
Imrnunol. 121,2228. 
OTrAVIO L, CHANC D, Rizzo MG, TTKAVALI S, CASADEVALL C, BASERGA R. ( 1  990) Importance of introns in 
the growth regulation of mRNA levels of the Proliferating Cell Nuclear Antigen gene. Mol.  Cell. Hiol. 
10.303. 
PKELICH G, TAN CK, KOSIUKA M el ul. (1987) Functional identity of proliferating cell nuclear antigen and ii 
DNA polymerase4 auxiliary protein. Nature 326, 5 17. 
Roos G, LANDBERC G, HUFF JP, HOUGHTEN R, TAKASAKI Y, TAN EM. (1993) Analysis of the epitope of 
proliferating cell nuclear antigen recognized by monoclonal antibodies. Lab. Invest. 68, 204. 
SASAKI K, KUKOSE A, ISHIDA Y. ( 1993) Flow cytometric analysis of the expression of PCNA during the cell 
cycle in HeLa cells and effects on the inhibition of DNA synthesis on it. Cytornetty 14,876. 
Sc tm RJ, HALL PA, HALDANE JS et a/. (1991) A comparison of immunohistochemical markers of cell 
proliferation with experimentally determined growth fraction. J .  lJathol. 165, 173. 
SCIHLUTEK C, DUCHROW M, WOHLENBERG C et al. ( 1  993) The proliferation-associated antigen of antibody Ki- 
67: A very large, ubiquitous nuclear protein with numerous repeated elements, reprcscnting a new kind 
of cell cycle-maintaining proteins. J .  Cell Riol. 123, 5 13. 
SiiivJi MKK, KENNY MK, WOOD RD. ( 1  992) Proliferating cell nuclear antigen is required for DNA excision 
repair. Cell 69, 367. 
SHKI’.S.I.HA P, YAMADA K, WADA T el ul. ( 1  992) Proliferating cell nuclear antigen in breast lesions: correlation 
of c-erbB-2 oncoprotein and EGF receptor and its clinicopathological significance in breast cancer. 
Virchows Archiv A. l’uthol. Anat. 421, 193. 
SrivALA LA, P R ~ S P E R I  E, Rossi R, BIANCHI L. (1993) Involvement of proliferating cell nuclear antigen in DNA 
repair after damage induced by genotoxic agents in human fibroblasts. Curcinogenesis 14, 2560. 
SuLimw RP, MOKIIMEK G .  (1993) Value of PCNA and Ki67 staining in breast cancer. J. <’/in. Puthi)/. 46. 
188. 
TEACUE K, EL-NAGGAR A. ( 1994) Comparative flow cytometric analysis o f  Proliferating Cell Nuclear Antigen 
(PCNA) antibodies in human solid neoplasms. Cytomerty 15.2 1. 
TOSCHI L, BRAVO R. ( 1988) Changes of cyclin/proliferating cell nuclear antigen distribution during repair 
synthesis. J. Cell. Riol. 107, 1623. 
VKIZ S. LEMAITRE JM, LElBoVlCl M, THIERRY N, M ~ C H A L I  M. ( I  992) Comparative analysis of the intracellular 
localization of c-rnyc, c-fos, and replicative proteins during cell cycle progression. Mol. (’ell. lliid. 12, 
3548. 
WENZ F, LOHK F, FLEN.I.JE M. (1994) Flow cytometric measurement of proliferating cell nuclear antigen 
(PCNA) in solid tumors. Strahlenther. Onkol. 170,235. 
characterization of proliferating cell nuclear antigen using the monoclonal antibody PC 1 0 .  Eitr. J. 
Cnncer 28A, 20 10. 
Y u  CCW, Wooos AL, LEVISON DA. (1992) The assessment of cellular proliferation by immuno- 
histochemistry: a review of currently available methods and their applications. Histochem. J. 24, 12 I ,  
WllSoN GD, CAMPLFJOHN RS, MARTINDALE CA, BROCK A, LANE DP, BARNES DM. (1992) Flow cylometric 
